[
    [
        {
            "time": "2023-10-01",
            "orginal_text": "顶尖投资人“擒牛”复盘：买定离手，熬住寂寞",
            "features": {
                "keywords": [
                    "顶尖投资人",
                    "擒牛",
                    "复盘",
                    "买定离手",
                    "熬住寂寞"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "顶尖投资人“擒牛”复盘：买定离手，熬住寂寞",
            "scores": {
                "News_content": "顶尖投资人“擒牛”复盘：买定离手，熬住寂寞",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 4,
                "Impact": 2,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "orginal_text": "今日药闻|君实生物与阿斯利康中国达成授权合作",
            "features": {
                "keywords": [
                    "君实生物",
                    "阿斯利康中国",
                    "授权合作",
                    "药闻"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "今日药闻|君实生物与阿斯利康中国达成授权合作",
            "scores": {
                "News_content": "今日药闻|君实生物与阿斯利康中国达成授权合作",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]